Evidence map›Paper›PMID 31908754›Full record

ArticleChemical science2019

Isomeric triazines exhibit unique profiles of bioorthogonal reactivity.

David N Kamber, Sean S Nguyen, Fang Liu, Jeffrey S Briggs, Hui-Wen Shih, R David Row, Zane G Long, K N Houk, Yong Liang, Jennifer A Prescher

Abstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. ηChemistry, an Asian journal · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Factors Controlling the Aluminum(I)-meta-Selective C-H Activation in Arenes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David N KamberDepartment of Chemistry , University of California , Irvine , California 92697 , USA . Email: jpresche@uci.edu.
Sean S NguyenDepartment of Chemistry , University of California , Irvine , California 92697 , USA . Email: jpresche@uci.edu.ORCID 0000-0002-1801-5521
Fang LiuDepartment of Chemistry and Biochemistry , University of California , Los Angeles , California 90095 , USA.ORCID 0000-0002-0046-8434
Jeffrey S BriggsDepartment of Chemistry , University of California , Irvine , California 92697 , USA . Email: jpresche@uci.edu.
Hui-Wen ShihDepartment of Chemistry , University of California , Irvine , California 92697 , USA . Email: jpresche@uci.edu.
R David RowDepartment of Chemistry , University of California , Irvine , California 92697 , USA . Email: jpresche@uci.edu.
Zane G LongDepartment of Chemistry , University of California , Irvine , California 92697 , USA . Email: jpresche@uci.edu.ORCID 0000-0002-3795-5551
K N HoukDepartment of Chemistry and Biochemistry , University of California , Los Angeles , California 90095 , USA.ORCID 0000-0002-8387-5261
Yong LiangState Key Laboratory of Coordination Chemistry , Jiangsu Key Laboratory of Advanced Organic Materials , School of Chemistry and Chemical Engineering , Nanjing University , Nanjing 210023 , China . Email: yongliang@nju.edu.cn.ORCID 0000-0001-5026-6710
Jennifer A PrescherDepartment of Chemistry , University of California , Irvine , California 92697 , USA . Email: jpresche@uci.edu.ORCID 0000-0002-9250-4702

Funding

Bioorthogonal CycloadditionsR01GM109078 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOUK, KENDALL N · 2015 to 2018
$1.1M
Cyclopropenones to assemble, analyze, and activate biomoleculesR01GM126226 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI PRESCHER, JENNIFER · 2018 to 2021
$1.1M
NIGMS NIH HHS R01 GM109078NIGMS NIH HHS R01 GM126226
6 · The paper itself

Abstract

Expanding the scope of bioorthogonal reactivity requires access to new and mutually compatible reagents. We report here that 1,2,4-triazines can be tuned to exhibit unique reaction profiles with biocompatible strained alkenes and alkynes. Computational analyses were used to identify candidate orthogonal reactions, and the predictions were experimentally verified. Notably, 5-substituted triazines, unlike their 6-substituted counterparts, undergo rapid [4 + 2] cycloadditions with a sterically encumbered strained alkyne. This unique, sterically controlled reactivity was exploited for dual bioorthogonal labeling. Mutually orthogonal triazines and cycloaddition chemistries will enable new multi-component imaging applications.

Identifiers

PMID31908754
PMCPMC6910137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.